Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (121-130 of 295) with videos related to

Pageof 30
Sort By:
Japanese Journal of Clinical Oncology|April 17, 2002
A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG 9410)Nobumasa Ikeda, Yasuhiro Shimada, Atsushi Ohtsu, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
Scientific Reports|September 22, 2019
Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblastsTomoya Takeda, Sota Doiyama, Junya Azumi, et al.
European Journal of Pharmacology|April 14, 2006
Different effects of optical isomers of the 5-HT1A receptor antagonist pyrapyridolol against postischemic guinea-pig myocardial dysfunction and apoptosis through the mitochondrial permeability transition poreLei Huang, Yoshihiro Hotta, Kunihiro Miyazeki, et al.
American Journal of Clinical Oncology|April 11, 2002
Prognostic factors for patients with metastatic colorectal cancer receiving protracted venous infusion of 5-FUYoshihisa Namiki, Kei Muro, Kuniaki Shirao, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patientsKan Yonemori, Hideo Kunitoh, Koji Tsuta, et al.
International Journal of Clinical Oncology|May 20, 2014
A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasisMasayuki Ohue, Tetsuya Hamaguchi, Yoshinori Ito, et al.
Anticancer Research|September 10, 2014
Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagusHitomi Sumiyoshi Okuma, Satoru Iwasa, Hirokazu Shoji, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modificationSatoru Iwasa, Yasuhide Yamada, Takeo Fukagawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 8, 2012
A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancerShunsuke Okazaki, Takako E Nakajima, Jun Hashimoto, et al.
Pageof 30

Showing results (121-130 of 295) with videos related to

Sort By:
Pageof 30
Japanese Journal of Clinical Oncology|April 17, 2002
A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG 9410)Nobumasa Ikeda, Yasuhiro Shimada, Atsushi Ohtsu, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
Scientific Reports|September 22, 2019
Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblastsTomoya Takeda, Sota Doiyama, Junya Azumi, et al.
European Journal of Pharmacology|April 14, 2006
Different effects of optical isomers of the 5-HT1A receptor antagonist pyrapyridolol against postischemic guinea-pig myocardial dysfunction and apoptosis through the mitochondrial permeability transition poreLei Huang, Yoshihiro Hotta, Kunihiro Miyazeki, et al.
American Journal of Clinical Oncology|April 11, 2002
Prognostic factors for patients with metastatic colorectal cancer receiving protracted venous infusion of 5-FUYoshihisa Namiki, Kei Muro, Kuniaki Shirao, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patientsKan Yonemori, Hideo Kunitoh, Koji Tsuta, et al.
International Journal of Clinical Oncology|May 20, 2014
A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasisMasayuki Ohue, Tetsuya Hamaguchi, Yoshinori Ito, et al.
Anticancer Research|September 10, 2014
Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagusHitomi Sumiyoshi Okuma, Satoru Iwasa, Hirokazu Shoji, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modificationSatoru Iwasa, Yasuhide Yamada, Takeo Fukagawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 8, 2012
A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancerShunsuke Okazaki, Takako E Nakajima, Jun Hashimoto, et al.
Pageof 30